Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
06/2000
06/27/2000CA2013960C Substituted dibenzofurans and methods of using same
06/22/2000WO2000036105A1 Prostacyclin-stimulating factor-2
06/22/2000WO2000036103A1 Cytokine receptor chain
06/22/2000WO2000035939A2 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035936A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035915A1 Piperazine derivatives
06/22/2000WO2000035911A1 Heteroaryl-cyclic acetals
06/22/2000WO2000035885A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
06/22/2000WO2000035871A1 Lactams
06/22/2000WO2000035855A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
06/22/2000WO2000035483A1 Methods and products for regulating lectin complement pathway associated complement activation
06/22/2000WO2000035461A1 Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic
06/22/2000WO2000035452A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035442A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000WO2000035428A2 Tricyclic nitrogen heterocycles as pde iv inhibitors
06/22/2000WO2000035417A1 Pharmaceutical preparation for inhalation of an opioid
06/22/2000WO2000035408A2 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil
06/22/2000WO2000012703A3 Protein transport-associated molecules
06/22/2000CA2440933A1 An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
06/22/2000CA2355890A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000CA2355775A1 Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic
06/22/2000CA2355363A1 Prostacyclin-stimulating factor-2
06/22/2000CA2354875A1 Piperazine derivatives
06/22/2000CA2354456A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2354422A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2353924A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
06/22/2000CA2351464A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
06/22/2000CA2347770A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000CA2345752A1 Tricyclic nitrogen heterocycles as pde iv inhibitors
06/22/2000CA2290220A1 An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
06/21/2000EP1010431A2 Botulinum toxins for treating pain associated with muscle spasms
06/21/2000EP1009806A2 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
06/21/2000EP1009760A2 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders
06/21/2000EP1009752A1 Novel molecules of the tango-77 related protein family and uses thereof
06/21/2000EP1009743A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
06/21/2000EP1009737A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
06/21/2000EP1009431A1 Human tumor necrosis factor receptor-like 2 (tr2) antibodies
06/21/2000EP1009413A2 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
06/21/2000EP1009408A1 New combination of antiasthma medicaments
06/21/2000EP1009394A1 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising formoterol
06/21/2000EP1009384A1 A method of administering liposomal encapsulated taxane
06/21/2000DE19858463A1 Verwendung eines Fibrinklebers zur Regeneration des Lebergewebes Use of fibrin glue for the regeneration of liver tissue
06/21/2000DE19858331A1 Tricyclische Stickstoffheterocyclen als PDE IV Inhibitoren Tricyclic nitrogen heterocycles as PDE IV inhibitors
06/21/2000CN1257538A Short peptides which selectively modulate the activity of serine/threonine kinases
06/21/2000CN1257500A 9-azabicyclo (3,3,1) non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ACH receptors
06/21/2000CN1257499A 8-Azabicyclo (3,2,1) oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACH receptors
06/21/2000CN1257424A Composition comprising finely divided, crystalling particles of budesonide
06/21/2000CN1257421A Medicinal aerosol products
06/21/2000CN1256942A Medicinal composition for treating cough and preparation process thereof
06/21/2000CN1256940A Lidanhoubao lozenge
06/21/2000CN1053582C Medicine composition for curing cold
06/21/2000CN1053578C Medicine for treating pneumonia
06/21/2000CN1053575C Capsule for removing heat from liver and relieving sore-throat and preparing method thereof
06/20/2000US6077854 Tri-substituted phenyl derivatives and processes for their preparation
06/20/2000CA2198536C Method of reducing tissue damage associated with ischemia
06/20/2000CA2013381C Selective adenosine receptor compounds
06/18/2000CA2292481A1 Use of fibrin adhesive for tissue regeneration
06/15/2000WO2000034516A1 Detection of rantes gene promotor polymorphisms
06/15/2000WO2000034451A1 Treatment of pompe's disease
06/15/2000WO2000034338A2 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
06/15/2000WO2000034334A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF
06/15/2000WO2000034332A1 Glp-1 analogues
06/15/2000WO2000034331A2 Analogues of glp-1
06/15/2000WO2000034313A1 Procollagen c-proteinase inhibitors
06/15/2000WO2000034295A2 Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
06/15/2000WO2000034258A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
06/15/2000WO2000034254A1 Novel compounds
06/15/2000WO2000034248A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
06/15/2000WO2000034244A1 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
06/15/2000WO2000034243A1 N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists
06/15/2000WO2000034228A1 Ion channel modulating agents
06/15/2000WO2000033878A2 Stabilization of macrolides
06/15/2000WO2000033876A1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors
06/15/2000WO2000033872A2 Method of and compositions for immunization with the pseudomonas v antigen
06/15/2000WO2000033863A2 Therapeutic agent for the suppression of snoring noises
06/15/2000WO2000033844A1 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
06/15/2000WO2000033838A1 Vitronectin receptor antagonist
06/15/2000WO2000033834A1 Use of isatin derivatives as ion channel activating agents
06/15/2000WO2000033828A1 Agent for lowering endothelin levels
06/15/2000WO2000033811A2 Improvements in or relating to powders
06/15/2000WO2000010598A3 Recombinant botulinium toxin for the treatment of mucus hypersecretion
06/15/2000WO2000010536A8 Extended release buccal bioadhesive tablet
06/15/2000WO2000006531A3 Nitric esters and nitrate salts of specific drugs
06/15/2000DE19857009A1 Zubereitung mit verbesserter therapeutischer Breite, enthaltend Nukleotidsyntheseinhibitoren Preparation with improved therapeutic index containing nucleotide synthesis
06/15/2000DE19856897A1 Therapeutikum zur Unterdrückung von Schnarchgeräuschen A therapeutic agent for suppressing snoring noises
06/15/2000CA2778047A1 Analogues of glp-1
06/15/2000CA2732620A1 Crystalline form of 40-o-(2-hydroxy-ethyl) rapamycin and process for preparation thereof
06/15/2000CA2651609A1 Crystalline form of 40-o- (2-hydroxy-ethyl) rapamycin and process for preparation thereof
06/15/2000CA2354266A1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors
06/15/2000CA2354150A1 Detection of rantes gene promotor polymorphisms
06/15/2000CA2354040A1 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
06/15/2000CA2353522A1 Treatment of pompe's disease
06/15/2000CA2353469A1 Therapeutic agent for the suppression of snoring noises
06/15/2000CA2353415A1 Vitronectin receptor antagonist
06/15/2000CA2352740A1 Procollagen c-proteinase inhibitors
06/15/2000CA2351060A1 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
06/15/2000CA2351059A1 Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
06/15/2000CA2350767A1 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
06/15/2000CA2349616A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
06/14/2000EP1007685A2 Surface exposed proteins from chlamydia pneumoniae
1 ... 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 ... 878